Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Lancet HIV. 2023 Sep 29;10(11):e703–e712. doi: 10.1016/S2352-3018(23)00200-X

Table 1.

Baseline demographic characteristics among TGW participants, by study arm.

Participants Enrolled TDF/FTC (n=304) CAB-LA (n=266)
n (%) n (%)
Self–identification
Female 43 (14.1) 47 (17.7)
Transgender male 0 (0.0) 0 (0.0)
Transgender female 213 (70.1) 187 (70.3)
Gender queer 18 (5.9) 14 (5.3)
Gender variant or gender non-confirming 27 (8.9) 16 (6.0)
Other self-identification 3 (1.0) 2 (0.8)
Prefer not to answer 0 (0.0) 0 (0.0)
Age
18-29 244 (80.3) 227 (85.3)
30-39 42 (13.8) 29 (10.9)
40+ 18 (6.0) 10 (3.7)
Median (IQR) 23 (21, 28) 23 (21, 27)
Geographic Region
US 71 (23.4) 54 (20.3)
Latin America 113 (37.2) 92 (34.6)
Asia 110 (36.2) 115 (43.2)
Africa 10 (3.3) 5 (1.9)
Education
Secondary or lower 143 (47.1) 125 (47.0)
Technical Training 22 (7.2) 24 (9.0)
College/University or Higher 139 (45.7) 117 (44.0)
Marital Status
Married/Civil Union/Legal Partnership 7 (2.3) 3 (1.1)
Living with Primary or Main Partner 14 (4.6) 16 (6.0)
Have primary or Main Partner, not living together 19 (6.3) 26 (9.8)
Single / Divorced / Widowed 264 (86.8) 219 (82.3)
Other 0 (0.0) 2 (0.8)
Employment Status
Full or part time 188 (61.8) 166 (62.4)
Not employed 116 (38.2) 100 (37.6)
Household monthy income (US Dollars) 1
Median (IQR) 482 (279, 955) 366 (195, 698)

CAB-LA: Cabotegravir; IQR: interquartile range; TDF/FTC: Tenofovir disoproxil fumarate/emtricitabine; TGW: transgender women.

1

Income of countries other than the US was converted from local currency to US Dollars using the exchange rate on Jan 1, 2017.